Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...
Benzinga’s FDA calendar is a user-friendly, dynamically updated investment tool that is a ‘must-have’ for those looking to capitalize on the volatility that is typical of trading biotech stocks. FDA ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Stella Osoba is the Senior Editor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results